| 2011 | | Development and validation of a model to predict advanced fibrosis in chronic hepatitis B virus-infected patients with high viral load and normal or minimally raised ALT. | 김영배, 정재연, 조성원 |
| 2017 | | Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver | 강대용, 김보현, 김순선, 김재근, 신성재, 유병무, 이광재, 이기명, 이제희, 정재연, 조성원, 조효정 |
| 2012 | | Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis | 정재연, 조성원 |
| 2013 | | Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B. | 정재연 |
| 2019 | | Effect of Fibroblast Growth Factor-2 and its Receptor Gene Polymorphisms on the Survival of Patients With Hepatitis B Virus-associated Hepatocellular Carcinoma | 김순선, 노충균, 신성재, 은정우, 이기명, 정재연, 조효정 |
| 2002 | | Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion. | 김진홍, 이기명, 조성원, 함기백 |
| 2014 | | Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis. | 김순선, 안선주, 임선교, 정재연, 조성원, 황재철 |
| 2023 | | Entecavir versus tenofovir on the recurrence of hepatitis B-related HCC after liver transplantation: A multicenter observational study | 김봉완 |
| 2001 | | Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases. | 왕희정, 조혜성 |
| 2016 | | Genetic polymorphisms in the Wnt/beta-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 노충균, 신성재, 유병무, 이광재, 이기명, 정재연, 조성원, 조효정 |
| 2018 | | Hepatitis B Virus Infection: Fatigue-Associated Illness Experiences Among Koreans | 부선주 |
| 2002 | | Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection. | 조혜성 |
| 2012 | | Hepatocellular carcinoma: clinical and radiological findings in patients with chronic B viral hepatitis and chronic C viral hepatitis | 김영철 |
| 2002 | | HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo. | 김형일 |
| 2017 | | Identification of novel OCT4 genetic variant associated with the risk of chronic hepatitis B in a Korean population | 조성원 |
| 2018 | | Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B | 우현구 |
| 2018 | | Impact of nucleos(t)ide analog treatment on the development of malignancy in patients with chronic hepatitis B | 김순선, 박래웅, 양민재, 정재연, 조성원, 조효정 |
| 2014 | | Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma | 김순선, 신성재, 안선주, 유병무, 이기명, 정재연, 조성원, 조효정 |
| 2012 | | Interleukin-1ß and interleukin-1 receptor accessory protein gene polymorphisms are associated with persistent hepatitis B virus infection | 김순선, 정재연, 조성원 |
| 2018 | | Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance | 김순선, 정재연 |
| 2010 | | Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance. | 고경현, 이명희, 정재연, 조성원 |
| 2014 | | MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B | 정재연, 조성원 |
| 2013 | | Multidrug-resistant hepatitis B virus resulting from sequential monotherapy with lamivudine, adefovir, and entecavir: clonal evolution during lamivudine plus adefovir therapy. | 김순선, 정재연, 조성원 |
| 2011 | | Non-invasive index for predicting significant liver fibrosis: comparison of diagnostic performances in patients with chronic hepatitis B and C | 김영배, 정재연, 조성원 |
| 2007 | | Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B. | 정재연, 조성원 |
| 2018 | | Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma | 김보현, 김순선, 김재근, 김진우, 김현지, 원제환, 이제희, 정재연, 조성원, 조효정 |
| 2013 | | Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence. | 정재연, 조성원 |
| 2020 | | Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovir | 김순선, 정재연 |
| 2022 | | Renal safety of tenofovir disoproxil fumarate and entecavir in liver transplant patients: a nationwide Korean registry study | 김봉완 |
| 2000 | | Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy. | 김진홍, 조성원, 함기백 |
| 2021 | | Role of immune cells in patients with hepatitis b virus‐related hepatocellular carcinoma | 정재연, 조효정 |
| 2011 | | Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels. | 김영배, 정재연, 조성원 |
| 2023 | | Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea | 김순선 |
| 2015 | | Tenofovir-based rescue therapy in chronic hepatitis B patients with suboptimal responses to adefovir with prior lamivudine resistance. | 김순선, 신성재, 유병무, 정재연, 조성원, 조효정 |
| 2011 | | Usefulness of multiple biomarkers for the prediction of significant fibrosis in chronic hepatitis B. | 김영배, 정재연, 조성원 |
